Enhancing ascites: An aid to CT diagnosis

Abdominal Imaging

Volumn 21, Issue 1, 1996, Pages 67-68

  Wise, S W ^a   DeMeo, J H ^a   Austin, R F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ascites; CT, contrast; Enhancement; Mass; Peritoneum

Indexed keywords

ANTINEOPLASTIC AGENT; IOPAMIDOL;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYSTADENOCARCINOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

ADULT; ASCITES; CONTRAST MEDIA; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IOPAMIDOL; OVARIAN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030024601     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900013     Document Type: Article

References (5)

1. Cooper C, Silverman PM, Davros WJ, Zeman RK. Delayed contrast enhancement of ascitic fluid on CT: frequency and significance. AJR 1993;161:787-790
2. Stork J. Intraperitoneal contrast agents for computed tomography. AJR 1985;145:300
3. Lindgreen I, et al. Drainage of radiographic contrast media from the abdominal cavity: experimental studies in rats [Abstract]. AJR 1969;93:482
4. Gosselin RE, Berndt WO. Diffusional transport of solutes through mesentery and peritoneum. J Theor Biol 1962;3:487-495
5. Karnovsky MJ. The ultrastructural basis of capillary permeability studies with peroxides as a tracer. J Cell Biol 1967;35:213-235